Valuation Colinz Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:02:23 2026-08-14 EDT			5-day change	1st Jan Change
79.87 ^INR	-4.06%		-2.54%	+48.93%

07-30	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06-17	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million,	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	40.82	34.74	107.6	160	94.59	182.5
Change	-	-14.89%	209.87%	48.62%	-40.87%	92.92%
Enterprise Value (EV) ¹	18.65	-2.149	60.43	105.4	30.29	133.4
Change	-	-111.53%	2,911.96%	74.47%	-71.27%	340.39%
P/E	31.3x	16.7x	31.8x	19.2x	19.5x	36.8x
PBR	0.6x	0.48x	1.4x	1.08x	1.06x	1.93x
PEG	-	0.3x	0.5x	0x	3.23x	17.76x
Capitalization / Revenue	0.54x	0.56x	1.54x	2.24x	1.35x	2.8x
EV / Revenue	0.25x	-0.03x	0.87x	1.47x	0.43x	2.04x
EV / EBITDA	6.16x	-0.65x	10.3x	16.7x	5.58x	26.9x
EV / EBIT	17.3x	-1.52x	15.7x	20.9x	7.34x	36.7x
EV / FCF	2.68x	-0.2x	8.87x	17.8x	4.12x	-7.62x
FCF Yield	37.3%	-506%	11.3%	5.62%	24.3%	-13.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.2854	0.4541	0.74	1.82	1.93	1.97
Distribution rate	-	-	-	-	-	-
Net sales ¹	76.03	61.59	69.74	71.55	70.3	65.28
EBITDA ¹	3.027	3.331	5.862	6.326	5.428	4.951
EBIT ¹	1.079	1.418	3.85	5.037	4.125	3.639
Net income ¹	1.304	2.076	3.393	4.574	4.867	4.966
Net Debt ¹	-22.17	-36.89	-47.22	-54.55	-64.3	-49.09
Reference price ²	8.93	7.60	23.55	35.00	37.55	72.44
Nbr of stocks (in thousands)	4,571	4,571	4,571	4,571	2,519	2,519
Announcement Date	9/2/20	8/30/21	8/24/22	8/29/23	8/29/24	8/28/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
COLINZ LABORATORIES LIMITED	-	-	-	-	2.2M
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.65x	6.69x	23.19x	0.88%	48.57B
OTSUKA HOLDINGS CO., LTD.	19.4x	2.3x	10.51x	1.32%	40.99B
CIPLA LIMITED	28.4x	3.46x	17.93x	0.89%	12.35B
ZYDUS LIFESCIENCES LIMITED	27.99x	3.98x	16.37x	0.6%	12.2B
KRKA, D. D.	18.73x	3.33x	11.58x	3.85%	9.08B
GEDEON RICHTER	8.97x	2.07x	5.38x	4.48%	7.41B
ONO PHARMACEUTICAL CO., LTD.	15.91x	2.06x	6.44x	3.24%	7.13B
GLENMARK PHARMACEUTICALS LIMITED	35.22x	4.02x	17.1x	0.23%	6.86B
Average	23.78x	3.49x	13.56x	1.94%	16.07B
Weighted average by Cap.	26.35x	4.14x	15.81x	1.44%